Adoptive transfer of in vitro‐expanded tumor‐infiltrating T cells, predominantly CD8+, has demonstrated efficacy in autologous murine models of liposarcoma [399], highlighting the therapeutic potential of T cell–based interventions in STSs. This evidence concerns the gene CD8A and neoplasm.